000 | 01060 a2200277 4500 | ||
---|---|---|---|
005 | 20250516032347.0 | ||
264 | 0 | _c20120529 | |
008 | 201205s 0 0 eng d | ||
022 | _a1873-4316 | ||
024 | 7 |
_a10.2174/138920112798868539 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPende, Aldo | |
245 | 0 | 0 |
_aAnti-inflammatory approaches to reduce acute cardiovascular events: not only benefits. _h[electronic resource] |
260 |
_bCurrent pharmaceutical biotechnology _cJan 2012 |
||
300 |
_a27-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aVaccination |
700 | 1 | _aDallegri, Franco | |
773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 13 _gno. 1 _gp. 27-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138920112798868539 _zAvailable from publisher's website |
999 |
_c20737529 _d20737529 |